Mesa Laboratories, Inc. (MLAB)
MLAB Stock Price Chart
Explore Mesa Laboratories, Inc. interactive price chart. Choose custom timeframes to analyze MLAB price movements and trends.
MLAB Company Profile
Discover essential business fundamentals and corporate details for Mesa Laboratories, Inc. (MLAB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Feb 1984
Employees
741.00
Website
https://www.mesalabs.comCEO
Gary Owens
Description
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
MLAB Financial Timeline
Browse a chronological timeline of Mesa Laboratories, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 31 Aug 2026
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend will be paid on 15 Sept 2026.
Upcoming earnings on 10 Aug 2026
EPS estimate is $2.63, while revenue estimate is $60.87m.
Dividend declared on 29 May 2026
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2026.
Earnings released on 27 May 2026
EPS came in at $2.76 surpassing the estimated $2.09 by +32.06%, while revenue for the quarter reached $63.72m , missing expectations by -2.28%.
Dividend declared on 27 Feb 2026
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Mar 2026.
Earnings released on 3 Feb 2026
EPS came in at $3.07 surpassing the estimated $1.40 by +119.29%, while revenue for the quarter reached $65.13m , beating expectations by +2.99%.
Dividend declared on 28 Nov 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2025.
Earnings released on 6 Nov 2025
EPS came in at $1.76 surpassing the estimated $1.56 by +12.82%, while revenue for the quarter reached $60.74m , missing expectations by -0.49%.
Dividend declared on 29 Aug 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2025.
Earnings released on 5 Aug 2025
EPS came in at $2.32 falling short of the estimated $2.46 by -5.69%, while revenue for the quarter reached $59.54m , missing expectations by -1.42%.
Dividend declared on 30 May 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Jun 2025.
Earnings released on 28 May 2025
EPS came in at $2.23 falling short of the estimated $2.75 by -18.91%, while revenue for the quarter reached $62.14m , beating expectations by +0.38%.
Dividend declared on 28 Feb 2025
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 17 Mar 2025.
Earnings released on 4 Feb 2025
EPS came in at $2.67 surpassing the estimated $1.41 by +89.36%, while revenue for the quarter reached $62.84m , beating expectations by +2.12%.
Dividend declared on 29 Nov 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Dec 2024.
Earnings released on 7 Nov 2024
EPS came in at $2.45 falling short of the estimated $2.48 by -1.21%, while revenue for the quarter reached $57.83m , missing expectations by -0.08%.
Dividend declared on 30 Aug 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 16 Sept 2024.
Earnings released on 5 Aug 2024
EPS came in at $2.83 surpassing the estimated $2.33 by +21.46%, while revenue for the quarter reached $58.17m , beating expectations by +4.36%.
Earnings released on 5 Jun 2024
EPS came in at $2.77 surpassing the estimated -$0.11 by +2.62k%, while revenue for the quarter reached $58.90m , beating expectations by +6.57%.
Dividend declared on 31 May 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 14 Jun 2024.
Dividend declared on 28 Feb 2024
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2024.
Earnings released on 5 Feb 2024
EPS came in at $2.02 falling short of the estimated $2.04 by -0.98%, while revenue for the quarter reached $53.47m , missing expectations by -0.98%.
Dividend declared on 29 Nov 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2023.
Earnings released on 6 Nov 2023
EPS came in at $1.91 surpassing the estimated $1.65 by +15.76%, while revenue for the quarter reached $53.17m , missing expectations by -2.72%.
Dividend declared on 30 Aug 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2023.
Earnings released on 3 Aug 2023
EPS came in at $1.77 surpassing the estimated $1.67 by +5.99%, while revenue for the quarter reached $50.65m , missing expectations by -2.32%.
Dividend declared on 30 May 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2023.
Earnings released on 25 May 2023
EPS came in at $1.94 falling short of the estimated $1.98 by -2.02%, while revenue for the quarter reached $55.59m , missing expectations by -3.15%.
Dividend declared on 27 Feb 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2023.
Earnings released on 6 Feb 2023
EPS came in at $2.35 surpassing the estimated $2.10 by +11.90%, while revenue for the quarter reached $54.29m , missing expectations by -4.83%.
Dividend declared on 29 Nov 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2022.
Earnings released on 3 Nov 2022
EPS came in at $2.88 surpassing the estimated $1.39 by +107.19%, while revenue for the quarter reached $58.75m , beating expectations by +10.35%.
Dividend declared on 30 Aug 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2022.
Earnings released on 4 Aug 2022
EPS came in at $1.17 falling short of the estimated $1.95 by -40.00%, while revenue for the quarter reached $50.45m , missing expectations by -3.30%.
Earnings released on 31 May 2022
EPS came in at $2.22 surpassing the estimated $1.88 by +18.09%, while revenue for the quarter reached $58.88m , beating expectations by +4.42%.
Dividend declared on 27 May 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jun 2022.
Dividend declared on 25 Feb 2022
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Mar 2022.
Earnings released on 3 Feb 2022
EPS came in at $1.36 falling short of the estimated $1.68 by -19.05%, while revenue for the quarter reached $54.70m , beating expectations by +13.63%.
Dividend declared on 29 Nov 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Dec 2021.
Earnings released on 4 Nov 2021
EPS came in at $1.87 surpassing the estimated $1.29 by +44.96%, while revenue for the quarter reached $35.84m , beating expectations by +24.00%.
Dividend declared on 30 Aug 2021
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 15 Sept 2021.
Earnings released on 5 Aug 2021
EPS came in at $1.28 falling short of the estimated $1.36 by -5.88%, while revenue for the quarter reached $34.92m , meeting expectations.
MLAB Stock Performance
Access detailed MLAB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
